BK2280 Medical Devices
- 1346.010
- +4.308+0.32%
Allurion Technologies Files to Sell 30.19M Shares of Common Stock for Holders
NeuroOne Medical Files $150M Mixed Securities Shelf
Zimmer Biomet Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 9.23% Barclays $130 → $125 Maintains Underweight 05/30/2024 12.72% Goldman Sachs → $129 Initiat
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
12 Health Care Stocks Moving In Friday's Intraday Session
GainersNovo Integrated Sciences (NASDAQ:NVOS) shares rose 120.0% to $0.99 during Friday's regular session. The company's market cap stands at $18.9 million. Anebulo Pharmaceuticals (NASDAQ:ANEB) share
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $17 Price Target
Cantor Fitzgerald analyst Ross Osborn reiterates Nano X Imaging (NASDAQ:NNOX) with a Overweight and maintains $17 price target.
Autonomix Medical FY24 Net Loss $15.4M
Autonomix Medical FY24 Net Loss $15.4M
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersNovo Integrated Sciences (NASDAQ:NVOS) stock moved upwards by 69.6% to $0.77 during Friday's pre-market session. The company's market cap stands at $14.5 million. Adaptimmune Therapeutics (NASD
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.47% on an annualized basis producing an average annual return of 18.34%. Currently, Edwards Lifesciences has a m
Nektar, Verastem Among Healthcare Additions in Russell Microcap; Assertio, Sangamo Removed
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersMyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 46.0% to $2.89 during Thursday's after-market session. The market value of their outstanding shares is at $6.6 million. Adaptimmune Therapeutics (N
SinTx Technologies Has Been Granted Australian Patent Number 2020334770 Titled "Methods Of Surface Functionalization Of Zirconia-toughened Alumina With Silicon Nitride (For Use On The Surface Of A Biomedical Implant To Promote Osteogenesis)".
SinTx Technologies Has Been Granted Australian Patent Number 2020334770 Titled "Methods Of Surface Functionalization Of Zirconia-toughened Alumina With Silicon Nitride (For Use On The Surface Of A Bio
Why Sarepta Therapeutics Stock Is Rising Today
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400.What Happened: Effective prior to the opening of tra
Why American Eagle Outfitters Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of American Eagle Outfitters, Inc. (NYSE:AEO) fell during Thursday's session following first-quarter results.American Eagle Outfitters reported adjusted earnings of 17 cents per share and quart
AVITA Spikes on FDA Nod for RECELL GO Cell Harvesting Device
Assessing Surmodics: Insights From 5 Financial Analysts
Surmodics (NASDAQ:SRDX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of their rec
Why Bruker (BRKR) Shares Are Falling During Thursday's Session
Bruker Corp (NASDAQ:BRKR) shares are trading lower by 6.6% to $67.80 during Thursday's session after the company announced a public offering of 6 million shares of its common stock.The offering comes
Cantor Fitzgerald Maintains Overweight on Nano X Imaging, Lowers Price Target to $17
Cantor Fitzgerald analyst Ross Osborn maintains Nano X Imaging (NASDAQ:NNOX) with a Overweight and lowers the price target from $18 to $17.
Nano X Imaging Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 97.67% Cantor Fitzgerald $18 → $17 Maintains Overweight 05/29/2024 109.3% Cantor Fitzgerald $18
Predictive Oncology, Augmedix, Cue Health Among Healthcare Movers